Johnson & Johnson
JNJ · As of 2026-08-28
$268.04
·
1.97%
Latest close & trailing twelve-month yield
Adjusted close price
Annualized Compounded Stock Growth
Annual dividends — last 10 years
Stock Volatility
Debug
Symbol index
- Stocks rows: 7132
- ETFs rows: 5245
- Symbol count: 12377
Company overview — JNJ
| Symbol | JNJ |
| AssetType | Common Stock |
| Name | Johnson & Johnson |
| Description |
ShowJohnson & Johnson (J&J) is an American multinational corporation founded in 1886 that develops medical devices, pharmaceuticals, and consumer packaged goods. Its common stock is a component of the Dow Jones Industrial Average and the company is ranked No. 36 on the 2021 Fortune 500 list of the largest United States corporations by total revenue. Johnson & Johnson is one of the world's most valuable companies, and is one of only two U.S.-based companies that has a prime credit rating of AAA, higher than that of the United States government. |
| CIK | 200406 |
| Exchange | NYSE |
| Currency | USD |
| Country | USA |
| Sector | HEALTHCARE |
| Industry | DRUG MANUFACTURERS - GENERAL |
| Address |
ShowONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK, NJ, UNITED STATES, 08933 |
| OfficialSite | https://www.jnj.com |
| FiscalYearEnd | December |
| LatestQuarter | 2026-06-30 |
| MarketCapitalization | $640.48 Billion |
| EBITDA | $34.87 Billion |
| PERatio | 30.87 |
| PEGRatio | 4.73 |
| BookValue | 35.28 |
| DividendPerShare | 5.24 |
| DividendYield | 0.0194 |
| EPS | 8.61 |
| RevenuePerShareTTM | 40.67 |
| ProfitMargin | 21.50% |
| OperatingMarginTTM | 29.20% |
| ReturnOnAssetsTTM | 8.60% |
| ReturnOnEquityTTM | 25.70% |
| RevenueTTM | $97.93 Billion |
| GrossProfitTTM | $66.73 Billion |
| DilutedEPSTTM | 8.61 |
| QuarterlyEarningsGrowthYOY | -0.009 |
| QuarterlyRevenueGrowthYOY | 0.066 |
| AnalystTargetPrice | 272.5 |
| AnalystRatingStrongBuy | 5 |
| AnalystRatingBuy | 11 |
| AnalystRatingHold | 6 |
| AnalystRatingSell | 1 |
| AnalystRatingStrongSell | 0 |
| TrailingPE | 30.87 |
| ForwardPE | 23.2 |
| PriceToSalesRatioTTM | 6.54 |
| PriceToBookRatio | 7.66 |
| EVToRevenue | 6.93 |
| EVToEBITDA | 19.99 |
| Beta | 0.231 |
| 52WeekHigh | 275.11 |
| 52WeekLow | 169.49 |
| 50DayMovingAverage | 257.47 |
| 200DayMovingAverage | 233.49 |
| SharesOutstanding | 2409899000 |
| SharesFloat | 2405995000 |
| PercentInsiders | 0.053 |
| PercentInstitutions | 76.887 |
| DividendDate | 2026-09-08 |
| ExDividendDate | 2026-08-25 |